nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PPARG—systemic lupus erythematosus	0.366	1	CbGaD
Pioglitazone—SLCO1B3—Mycophenolate mofetil—systemic lupus erythematosus	0.0688	0.15	CbGbCtD
Pioglitazone—SLCO1B1—Mycophenolate mofetil—systemic lupus erythematosus	0.0401	0.0876	CbGbCtD
Pioglitazone—PTGS1—Dapsone—systemic lupus erythematosus	0.0339	0.0741	CbGbCtD
Pioglitazone—SLCO1B1—Cyclosporine—systemic lupus erythematosus	0.0304	0.0664	CbGbCtD
Pioglitazone—SLCO1B3—Methotrexate—systemic lupus erythematosus	0.0276	0.0603	CbGbCtD
Pioglitazone—CYP2C8—Dapsone—systemic lupus erythematosus	0.0196	0.0428	CbGbCtD
Pioglitazone—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0192	0.0419	CbGbCtD
Pioglitazone—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.017	0.0371	CbGbCtD
Pioglitazone—CYP2C19—Dapsone—systemic lupus erythematosus	0.0164	0.0359	CbGbCtD
Pioglitazone—SLCO1B1—Methotrexate—systemic lupus erythematosus	0.0161	0.0351	CbGbCtD
Pioglitazone—CYP2C9—Dapsone—systemic lupus erythematosus	0.0136	0.0298	CbGbCtD
Pioglitazone—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0136	0.0297	CbGbCtD
Pioglitazone—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0129	0.0281	CbGbCtD
Pioglitazone—CYP2C19—Prednisone—systemic lupus erythematosus	0.0114	0.0249	CbGbCtD
Pioglitazone—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0108	0.0236	CbGbCtD
Pioglitazone—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00908	0.0198	CbGbCtD
Pioglitazone—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00897	0.0196	CbGbCtD
Pioglitazone—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00847	0.0185	CbGbCtD
Pioglitazone—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0082	0.0179	CbGbCtD
Pioglitazone—CYP2C9—cardial valve—systemic lupus erythematosus	0.00811	0.216	CbGeAlD
Pioglitazone—CYP3A4—Dapsone—systemic lupus erythematosus	0.00794	0.0173	CbGbCtD
Pioglitazone—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0071	0.0155	CbGbCtD
Pioglitazone—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00688	0.015	CbGbCtD
Pioglitazone—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00688	0.015	CbGbCtD
Pioglitazone—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00591	0.0129	CbGbCtD
Pioglitazone—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0059	0.0129	CbGbCtD
Pioglitazone—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00582	0.0127	CbGbCtD
Pioglitazone—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00552	0.0121	CbGbCtD
Pioglitazone—CYP3A4—Prednisone—systemic lupus erythematosus	0.0055	0.012	CbGbCtD
Pioglitazone—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.0054	0.0118	CbGbCtD
Pioglitazone—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00521	0.0114	CbGbCtD
Pioglitazone—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00343	0.0075	CbGbCtD
Pioglitazone—CYP2C19—urine—systemic lupus erythematosus	0.00226	0.06	CbGeAlD
Pioglitazone—SLCO1B1—blood plasma—systemic lupus erythematosus	0.00181	0.0481	CbGeAlD
Pioglitazone—PPARG—endothelium—systemic lupus erythematosus	0.00176	0.0467	CbGeAlD
Pioglitazone—CYP2C9—urine—systemic lupus erythematosus	0.00175	0.0465	CbGeAlD
Pioglitazone—Rosiglitazone—PPARG—systemic lupus erythematosus	0.00167	0.727	CrCbGaD
Pioglitazone—PPARG—blood plasma—systemic lupus erythematosus	0.00156	0.0415	CbGeAlD
Pioglitazone—CYP3A4—urine—systemic lupus erythematosus	0.00133	0.0355	CbGeAlD
Pioglitazone—CYP2D6—urine—systemic lupus erythematosus	0.00131	0.0349	CbGeAlD
Pioglitazone—CYP2C19—blood plasma—systemic lupus erythematosus	0.00118	0.0313	CbGeAlD
Pioglitazone—CYP2C8—blood plasma—systemic lupus erythematosus	0.00103	0.0273	CbGeAlD
Pioglitazone—SLCO1B3—lung—systemic lupus erythematosus	0.001	0.0267	CbGeAlD
Pioglitazone—PTGS1—endothelium—systemic lupus erythematosus	0.000939	0.025	CbGeAlD
Pioglitazone—CYP2C9—blood plasma—systemic lupus erythematosus	0.000913	0.0243	CbGeAlD
Pioglitazone—PTGS1—blood plasma—systemic lupus erythematosus	0.000834	0.0222	CbGeAlD
Pioglitazone—PPARG—connective tissue—systemic lupus erythematosus	0.00083	0.0221	CbGeAlD
Pioglitazone—SLCO1B1—kidney—systemic lupus erythematosus	0.00082	0.0218	CbGeAlD
Pioglitazone—PPARG—skin of body—systemic lupus erythematosus	0.00075	0.0199	CbGeAlD
Pioglitazone—PPARG—kidney—systemic lupus erythematosus	0.000707	0.0188	CbGeAlD
Pioglitazone—CYP3A4—blood plasma—systemic lupus erythematosus	0.000696	0.0185	CbGeAlD
Pioglitazone—CYP2D6—blood plasma—systemic lupus erythematosus	0.000685	0.0182	CbGeAlD
Pioglitazone—Rosiglitazone—ALB—systemic lupus erythematosus	0.000629	0.273	CrCbGaD
Pioglitazone—PPARG—lymphoid tissue—systemic lupus erythematosus	0.000607	0.0161	CbGeAlD
Pioglitazone—PPARG—tendon—systemic lupus erythematosus	0.000571	0.0152	CbGeAlD
Pioglitazone—PPARG—bone marrow—systemic lupus erythematosus	0.000553	0.0147	CbGeAlD
Pioglitazone—PPARG—lung—systemic lupus erythematosus	0.000501	0.0133	CbGeAlD
Pioglitazone—CYP2C8—kidney—systemic lupus erythematosus	0.000466	0.0124	CbGeAlD
Pioglitazone—PPARG—nervous system—systemic lupus erythematosus	0.000464	0.0123	CbGeAlD
Pioglitazone—PPARG—central nervous system—systemic lupus erythematosus	0.000447	0.0119	CbGeAlD
Pioglitazone—PTGS1—connective tissue—systemic lupus erythematosus	0.000444	0.0118	CbGeAlD
Pioglitazone—PTGS1—skin of body—systemic lupus erythematosus	0.000401	0.0107	CbGeAlD
Pioglitazone—PTGS1—kidney—systemic lupus erythematosus	0.000378	0.0101	CbGeAlD
Pioglitazone—CYP3A4—kidney—systemic lupus erythematosus	0.000316	0.0084	CbGeAlD
Pioglitazone—CYP2D6—kidney—systemic lupus erythematosus	0.000311	0.00826	CbGeAlD
Pioglitazone—PTGS1—tendon—systemic lupus erythematosus	0.000305	0.00812	CbGeAlD
Pioglitazone—PTGS1—lung—systemic lupus erythematosus	0.000268	0.00712	CbGeAlD
Pioglitazone—PTGS1—nervous system—systemic lupus erythematosus	0.000248	0.0066	CbGeAlD
Pioglitazone—PTGS1—central nervous system—systemic lupus erythematosus	0.000239	0.00635	CbGeAlD
Pioglitazone—CYP3A4—nervous system—systemic lupus erythematosus	0.000207	0.00551	CbGeAlD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—systemic lupus erythematosus	0.000207	0.0165	CbGpPWpGaD
Pioglitazone—CYP2D6—nervous system—systemic lupus erythematosus	0.000204	0.00542	CbGeAlD
Pioglitazone—CYP3A4—central nervous system—systemic lupus erythematosus	0.000199	0.0053	CbGeAlD
Pioglitazone—PPARG—Transcription factor regulation in adipogenesis—NR3C1—systemic lupus erythematosus	0.000197	0.0158	CbGpPWpGaD
Pioglitazone—CYP2D6—central nervous system—systemic lupus erythematosus	0.000196	0.00522	CbGeAlD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—VDR—systemic lupus erythematosus	0.000192	0.0154	CbGpPWpGaD
Pioglitazone—SLCO1B3—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000191	0.0153	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transport of organic anions—ALB—systemic lupus erythematosus	0.000188	0.0151	CbGpPWpGaD
Pioglitazone—PPARG—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000156	0.0125	CbGpPWpGaD
Pioglitazone—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000155	0.0124	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000155	0.0124	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUNB—systemic lupus erythematosus	0.000143	0.0115	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—systemic lupus erythematosus	0.000142	0.0114	CbGpPWpGaD
Pioglitazone—PPARG—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000142	0.0113	CbGpPWpGaD
Pioglitazone—PTGS1—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000141	0.0113	CbGpPWpGaD
Pioglitazone—SLCO1B1—Recycling of bile acids and salts—ALB—systemic lupus erythematosus	0.00014	0.0112	CbGpPWpGaD
Pioglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000139	0.0111	CbGpPWpGaD
Pioglitazone—SLCO1B1—Bile acid and bile salt metabolism—RXRA—systemic lupus erythematosus	0.000129	0.0103	CbGpPWpGaD
Pioglitazone—PPARG—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000127	0.0102	CbGpPWpGaD
Pioglitazone—Breast disorder—Methotrexate—systemic lupus erythematosus	0.000127	0.00103	CcSEcCtD
Pioglitazone—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000126	0.00102	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.000126	0.00102	CcSEcCtD
Pioglitazone—Ill-defined disorder—Hydrocortisone—systemic lupus erythematosus	0.000126	0.00102	CcSEcCtD
Pioglitazone—Malaise—Prednisolone—systemic lupus erythematosus	0.000125	0.00102	CcSEcCtD
Pioglitazone—Discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000125	0.00102	CcSEcCtD
Pioglitazone—Vertigo—Prednisolone—systemic lupus erythematosus	0.000125	0.00101	CcSEcCtD
Pioglitazone—Anaphylactic shock—Cyclosporine—systemic lupus erythematosus	0.000125	0.00101	CcSEcCtD
Pioglitazone—Oedema—Cyclosporine—systemic lupus erythematosus	0.000125	0.00101	CcSEcCtD
Pioglitazone—Eye disorder—Dexamethasone—systemic lupus erythematosus	0.000125	0.00101	CcSEcCtD
Pioglitazone—Eye disorder—Betamethasone—systemic lupus erythematosus	0.000125	0.00101	CcSEcCtD
Pioglitazone—Angioedema—Hydrocortisone—systemic lupus erythematosus	0.000124	0.00101	CcSEcCtD
Pioglitazone—Infection—Cyclosporine—systemic lupus erythematosus	0.000124	0.001	CcSEcCtD
Pioglitazone—Back pain—Triamcinolone—systemic lupus erythematosus	0.000124	0.001	CcSEcCtD
Pioglitazone—PPARG—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000124	0.00989	CbGpPWpGaD
Pioglitazone—Malaise—Hydrocortisone—systemic lupus erythematosus	0.000123	0.000993	CcSEcCtD
Pioglitazone—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.000122	0.000991	CcSEcCtD
Pioglitazone—Vertigo—Hydrocortisone—systemic lupus erythematosus	0.000122	0.000989	CcSEcCtD
Pioglitazone—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.000986	CcSEcCtD
Pioglitazone—Anaphylactic shock—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.000986	CcSEcCtD
Pioglitazone—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000121	0.000982	CcSEcCtD
Pioglitazone—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000121	0.00098	CcSEcCtD
Pioglitazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—systemic lupus erythematosus	0.000121	0.00968	CbGpPWpGaD
Pioglitazone—Hyperhidrosis—Cyclosporine—systemic lupus erythematosus	0.000121	0.000977	CcSEcCtD
Pioglitazone—Hypertension—Prednisolone—systemic lupus erythematosus	0.00012	0.000973	CcSEcCtD
Pioglitazone—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000119	0.000967	CcSEcCtD
Pioglitazone—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000119	0.000965	CcSEcCtD
Pioglitazone—Ill-defined disorder—Triamcinolone—systemic lupus erythematosus	0.000119	0.000962	CcSEcCtD
Pioglitazone—Ill-defined disorder—Methylprednisolone—systemic lupus erythematosus	0.000118	0.00096	CcSEcCtD
Pioglitazone—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.000958	CcSEcCtD
Pioglitazone—Hyperhidrosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000118	0.000953	CcSEcCtD
Pioglitazone—Hypertension—Hydrocortisone—systemic lupus erythematosus	0.000117	0.00095	CcSEcCtD
Pioglitazone—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000117	0.000949	CcSEcCtD
Pioglitazone—Discomfort—Prednisolone—systemic lupus erythematosus	0.000117	0.000948	CcSEcCtD
Pioglitazone—Angioedema—Triamcinolone—systemic lupus erythematosus	0.000117	0.000947	CcSEcCtD
Pioglitazone—Angioedema—Methylprednisolone—systemic lupus erythematosus	0.000117	0.000945	CcSEcCtD
Pioglitazone—Asthenia—Leflunomide—systemic lupus erythematosus	0.000116	0.00094	CcSEcCtD
Pioglitazone—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.000116	0.000937	CcSEcCtD
Pioglitazone—Malaise—Triamcinolone—systemic lupus erythematosus	0.000115	0.000935	CcSEcCtD
Pioglitazone—Malaise—Methylprednisolone—systemic lupus erythematosus	0.000115	0.000933	CcSEcCtD
Pioglitazone—Vertigo—Triamcinolone—systemic lupus erythematosus	0.000115	0.000931	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000115	0.000931	CcSEcCtD
Pioglitazone—Vertigo—Methylprednisolone—systemic lupus erythematosus	0.000115	0.000929	CcSEcCtD
Pioglitazone—Discomfort—Hydrocortisone—systemic lupus erythematosus	0.000114	0.000926	CcSEcCtD
Pioglitazone—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.000114	0.000925	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000114	0.000921	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000114	0.00092	CcSEcCtD
Pioglitazone—Oedema—Prednisolone—systemic lupus erythematosus	0.000114	0.00092	CcSEcCtD
Pioglitazone—Dizziness—Azathioprine—systemic lupus erythematosus	0.000113	0.000917	CcSEcCtD
Pioglitazone—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000113	0.000914	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Methotrexate—systemic lupus erythematosus	0.000113	0.000913	CcSEcCtD
Pioglitazone—PPARG—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000112	0.00896	CbGpPWpGaD
Pioglitazone—Erectile dysfunction—Methotrexate—systemic lupus erythematosus	0.000112	0.000905	CcSEcCtD
Pioglitazone—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000111	0.000901	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000111	0.000899	CcSEcCtD
Pioglitazone—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000111	0.000898	CcSEcCtD
Pioglitazone—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.000111	0.000898	CcSEcCtD
Pioglitazone—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000111	0.000896	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—systemic lupus erythematosus	0.000111	0.00885	CbGpPWpGaD
Pioglitazone—Hypertension—Triamcinolone—systemic lupus erythematosus	0.00011	0.000895	CcSEcCtD
Pioglitazone—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.00011	0.00884	CbGpPWpGaD
Pioglitazone—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.00011	0.000893	CcSEcCtD
Pioglitazone—Infection—Hydrocortisone—systemic lupus erythematosus	0.00011	0.000893	CcSEcCtD
Pioglitazone—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.00011	0.000892	CcSEcCtD
Pioglitazone—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	0.00011	0.000889	CcSEcCtD
Pioglitazone—Myalgia—Triamcinolone—systemic lupus erythematosus	0.000109	0.000883	CcSEcCtD
Pioglitazone—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000109	0.000881	CcSEcCtD
Pioglitazone—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000109	0.000881	CcSEcCtD
Pioglitazone—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.000109	0.000881	CcSEcCtD
Pioglitazone—SLCO1B3—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	0.000109	0.0087	CbGpPWpGaD
Pioglitazone—Eye disorder—Prednisone—systemic lupus erythematosus	0.000109	0.000879	CcSEcCtD
Pioglitazone—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000109	0.000879	CcSEcCtD
Pioglitazone—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.000108	0.000876	CcSEcCtD
Pioglitazone—Infestation—Methotrexate—systemic lupus erythematosus	0.000108	0.000876	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000108	0.000874	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000108	0.000873	CcSEcCtD
Pioglitazone—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000108	0.000873	CcSEcCtD
Pioglitazone—Ill-defined disorder—Dexamethasone—systemic lupus erythematosus	0.000108	0.000873	CcSEcCtD
Pioglitazone—Ill-defined disorder—Betamethasone—systemic lupus erythematosus	0.000108	0.000873	CcSEcCtD
Pioglitazone—Discomfort—Triamcinolone—systemic lupus erythematosus	0.000108	0.000872	CcSEcCtD
Pioglitazone—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000108	0.000872	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—systemic lupus erythematosus	0.000108	0.00861	CbGpPWpGaD
Pioglitazone—Discomfort—Methylprednisolone—systemic lupus erythematosus	0.000107	0.00087	CcSEcCtD
Pioglitazone—Headache—Azathioprine—systemic lupus erythematosus	0.000107	0.000869	CcSEcCtD
Pioglitazone—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	0.000107	0.000869	CcSEcCtD
Pioglitazone—Dizziness—Leflunomide—systemic lupus erythematosus	0.000107	0.000866	CcSEcCtD
Pioglitazone—Angioedema—Betamethasone—systemic lupus erythematosus	0.000106	0.000859	CcSEcCtD
Pioglitazone—Angioedema—Dexamethasone—systemic lupus erythematosus	0.000106	0.000859	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000105	0.000851	CcSEcCtD
Pioglitazone—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000105	0.00085	CcSEcCtD
Pioglitazone—Malaise—Betamethasone—systemic lupus erythematosus	0.000105	0.000848	CcSEcCtD
Pioglitazone—Malaise—Dexamethasone—systemic lupus erythematosus	0.000105	0.000848	CcSEcCtD
Pioglitazone—Oedema—Triamcinolone—systemic lupus erythematosus	0.000104	0.000846	CcSEcCtD
Pioglitazone—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000104	0.000846	CcSEcCtD
Pioglitazone—Vertigo—Betamethasone—systemic lupus erythematosus	0.000104	0.000845	CcSEcCtD
Pioglitazone—Vertigo—Dexamethasone—systemic lupus erythematosus	0.000104	0.000845	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000104	0.000844	CcSEcCtD
Pioglitazone—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	0.000104	0.00833	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000104	0.00831	CbGpPWpGaD
Pioglitazone—Infection—Triamcinolone—systemic lupus erythematosus	0.000104	0.00084	CcSEcCtD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—systemic lupus erythematosus	0.000104	0.0083	CbGpPWpGaD
Pioglitazone—Sweating—Methotrexate—systemic lupus erythematosus	0.000104	0.00084	CcSEcCtD
Pioglitazone—Infection—Methylprednisolone—systemic lupus erythematosus	0.000104	0.000839	CcSEcCtD
Pioglitazone—Haematuria—Methotrexate—systemic lupus erythematosus	0.000103	0.000835	CcSEcCtD
Pioglitazone—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000103	0.000833	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—systemic lupus erythematosus	0.000103	0.00823	CbGpPWpGaD
Pioglitazone—Insomnia—Prednisolone—systemic lupus erythematosus	0.000103	0.000832	CcSEcCtD
Pioglitazone—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000102	0.000828	CcSEcCtD
Pioglitazone—Headache—Leflunomide—systemic lupus erythematosus	0.000101	0.000821	CcSEcCtD
Pioglitazone—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000101	0.00082	CcSEcCtD
Pioglitazone—Malnutrition—Prednisone—systemic lupus erythematosus	0.000101	0.000819	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000101	0.000819	CcSEcCtD
Pioglitazone—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000101	0.000818	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000101	0.000816	CcSEcCtD
Pioglitazone—PPARG—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	0.000101	0.00806	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.0001	0.000813	CcSEcCtD
Pioglitazone—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.0001	0.000813	CcSEcCtD
Pioglitazone—Hypertension—Dexamethasone—systemic lupus erythematosus	0.0001	0.000812	CcSEcCtD
Pioglitazone—Hypertension—Betamethasone—systemic lupus erythematosus	0.0001	0.000812	CcSEcCtD
Pioglitazone—Urticaria—Cyclosporine—systemic lupus erythematosus	9.92e-05	0.000803	CcSEcCtD
Pioglitazone—Myalgia—Betamethasone—systemic lupus erythematosus	9.89e-05	0.000801	CcSEcCtD
Pioglitazone—Myalgia—Dexamethasone—systemic lupus erythematosus	9.89e-05	0.000801	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—systemic lupus erythematosus	9.86e-05	0.00789	CbGpPWpGaD
Pioglitazone—Discomfort—Betamethasone—systemic lupus erythematosus	9.77e-05	0.000791	CcSEcCtD
Pioglitazone—Discomfort—Dexamethasone—systemic lupus erythematosus	9.77e-05	0.000791	CcSEcCtD
Pioglitazone—Hepatitis—Methotrexate—systemic lupus erythematosus	9.71e-05	0.000786	CcSEcCtD
Pioglitazone—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	9.67e-05	0.000783	CcSEcCtD
Pioglitazone—Pharyngitis—Methotrexate—systemic lupus erythematosus	9.64e-05	0.00078	CcSEcCtD
Pioglitazone—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	9.59e-05	0.000777	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	9.58e-05	0.000776	CcSEcCtD
Pioglitazone—Fatigue—Hydrocortisone—systemic lupus erythematosus	9.56e-05	0.000775	CcSEcCtD
Pioglitazone—Urethral disorder—Methotrexate—systemic lupus erythematosus	9.52e-05	0.000771	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	9.52e-05	0.000771	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	9.49e-05	0.000769	CcSEcCtD
Pioglitazone—Oedema—Dexamethasone—systemic lupus erythematosus	9.48e-05	0.000768	CcSEcCtD
Pioglitazone—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	9.48e-05	0.000768	CcSEcCtD
Pioglitazone—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	9.48e-05	0.000768	CcSEcCtD
Pioglitazone—Oedema—Betamethasone—systemic lupus erythematosus	9.48e-05	0.000768	CcSEcCtD
Pioglitazone—PTGS1—Overview of nanoparticle effects—PTGS2—systemic lupus erythematosus	9.47e-05	0.00758	CbGpPWpGaD
Pioglitazone—Insomnia—Triamcinolone—systemic lupus erythematosus	9.45e-05	0.000765	CcSEcCtD
Pioglitazone—Insomnia—Methylprednisolone—systemic lupus erythematosus	9.43e-05	0.000763	CcSEcCtD
Pioglitazone—Infection—Dexamethasone—systemic lupus erythematosus	9.41e-05	0.000763	CcSEcCtD
Pioglitazone—Infection—Betamethasone—systemic lupus erythematosus	9.41e-05	0.000763	CcSEcCtD
Pioglitazone—Ill-defined disorder—Prednisone—systemic lupus erythematosus	9.38e-05	0.00076	CcSEcCtD
Pioglitazone—Feeling abnormal—Prednisolone—systemic lupus erythematosus	9.36e-05	0.000758	CcSEcCtD
Pioglitazone—Visual impairment—Methotrexate—systemic lupus erythematosus	9.36e-05	0.000758	CcSEcCtD
Pioglitazone—Anaemia—Prednisone—systemic lupus erythematosus	9.35e-05	0.000757	CcSEcCtD
Pioglitazone—Dyspnoea—Triamcinolone—systemic lupus erythematosus	9.31e-05	0.000754	CcSEcCtD
Pioglitazone—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	9.29e-05	0.000753	CcSEcCtD
Pioglitazone—Nervous system disorder—Betamethasone—systemic lupus erythematosus	9.29e-05	0.000753	CcSEcCtD
Pioglitazone—Angioedema—Prednisone—systemic lupus erythematosus	9.24e-05	0.000748	CcSEcCtD
Pioglitazone—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	9.2e-05	0.000745	CcSEcCtD
Pioglitazone—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	9.16e-05	0.000742	CcSEcCtD
Pioglitazone—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	9.16e-05	0.000742	CcSEcCtD
Pioglitazone—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	9.14e-05	0.00074	CcSEcCtD
Pioglitazone—Malaise—Prednisone—systemic lupus erythematosus	9.12e-05	0.000739	CcSEcCtD
Pioglitazone—Vertigo—Prednisone—systemic lupus erythematosus	9.09e-05	0.000736	CcSEcCtD
Pioglitazone—Eye disorder—Methotrexate—systemic lupus erythematosus	9.07e-05	0.000735	CcSEcCtD
Pioglitazone—Urticaria—Prednisolone—systemic lupus erythematosus	9.02e-05	0.000731	CcSEcCtD
Pioglitazone—Cardiac disorder—Methotrexate—systemic lupus erythematosus	9.01e-05	0.00073	CcSEcCtD
Pioglitazone—Fatigue—Triamcinolone—systemic lupus erythematosus	9e-05	0.000729	CcSEcCtD
Pioglitazone—Fatigue—Methylprednisolone—systemic lupus erythematosus	8.98e-05	0.000728	CcSEcCtD
Pioglitazone—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	8.97e-05	0.000727	CcSEcCtD
Pioglitazone—Asthenia—Cyclosporine—systemic lupus erythematosus	8.95e-05	0.000725	CcSEcCtD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—RXRA—systemic lupus erythematosus	8.89e-05	0.00711	CbGpPWpGaD
Pioglitazone—Urticaria—Hydrocortisone—systemic lupus erythematosus	8.81e-05	0.000714	CcSEcCtD
Pioglitazone—Immune system disorder—Methotrexate—systemic lupus erythematosus	8.77e-05	0.00071	CcSEcCtD
Pioglitazone—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	8.75e-05	0.000709	CcSEcCtD
Pioglitazone—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	8.74e-05	0.000708	CcSEcCtD
Pioglitazone—Hypertension—Prednisone—systemic lupus erythematosus	8.73e-05	0.000707	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	8.63e-05	0.000699	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	8.63e-05	0.000699	CcSEcCtD
Pioglitazone—Arthralgia—Prednisone—systemic lupus erythematosus	8.61e-05	0.000697	CcSEcCtD
Pioglitazone—Myalgia—Prednisone—systemic lupus erythematosus	8.61e-05	0.000697	CcSEcCtD
Pioglitazone—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	8.61e-05	0.000697	CcSEcCtD
Pioglitazone—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	8.59e-05	0.000696	CcSEcCtD
Pioglitazone—Insomnia—Dexamethasone—systemic lupus erythematosus	8.57e-05	0.000694	CcSEcCtD
Pioglitazone—Insomnia—Betamethasone—systemic lupus erythematosus	8.57e-05	0.000694	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	8.55e-05	0.000693	CcSEcCtD
Pioglitazone—Diarrhoea—Cyclosporine—systemic lupus erythematosus	8.54e-05	0.000692	CcSEcCtD
Pioglitazone—Discomfort—Prednisone—systemic lupus erythematosus	8.51e-05	0.000689	CcSEcCtD
Pioglitazone—Malnutrition—Methotrexate—systemic lupus erythematosus	8.45e-05	0.000685	CcSEcCtD
Pioglitazone—Hypersensitivity—Prednisolone—systemic lupus erythematosus	8.37e-05	0.000678	CcSEcCtD
Pioglitazone—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	8.33e-05	0.000675	CcSEcCtD
Pioglitazone—Urticaria—Triamcinolone—systemic lupus erythematosus	8.3e-05	0.000672	CcSEcCtD
Pioglitazone—Urticaria—Methylprednisolone—systemic lupus erythematosus	8.28e-05	0.000671	CcSEcCtD
Pioglitazone—Dizziness—Cyclosporine—systemic lupus erythematosus	8.25e-05	0.000669	CcSEcCtD
Pioglitazone—Oedema—Prednisone—systemic lupus erythematosus	8.25e-05	0.000668	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisone—systemic lupus erythematosus	8.25e-05	0.000668	CcSEcCtD
Pioglitazone—Infection—Prednisone—systemic lupus erythematosus	8.2e-05	0.000664	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	8.18e-05	0.000663	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	8.18e-05	0.000663	CcSEcCtD
Pioglitazone—Back pain—Methotrexate—systemic lupus erythematosus	8.17e-05	0.000662	CcSEcCtD
Pioglitazone—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	8.17e-05	0.000662	CcSEcCtD
Pioglitazone—Fatigue—Betamethasone—systemic lupus erythematosus	8.17e-05	0.000662	CcSEcCtD
Pioglitazone—Fatigue—Dexamethasone—systemic lupus erythematosus	8.17e-05	0.000662	CcSEcCtD
Pioglitazone—PPARG—Transcription factor regulation in adipogenesis—TNF—systemic lupus erythematosus	8.12e-05	0.0065	CbGpPWpGaD
Pioglitazone—Nervous system disorder—Prednisone—systemic lupus erythematosus	8.09e-05	0.000656	CcSEcCtD
Pioglitazone—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	8.05e-05	0.000652	CcSEcCtD
Pioglitazone—Skin disorder—Prednisone—systemic lupus erythematosus	8.02e-05	0.000649	CcSEcCtD
Pioglitazone—Hyperhidrosis—Prednisone—systemic lupus erythematosus	7.98e-05	0.000646	CcSEcCtD
Pioglitazone—Asthenia—Hydrocortisone—systemic lupus erythematosus	7.96e-05	0.000645	CcSEcCtD
Pioglitazone—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	7.86e-05	0.00629	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	7.86e-05	0.00629	CbGpPWpGaD
Pioglitazone—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	7.84e-05	0.000635	CcSEcCtD
Pioglitazone—Headache—Cyclosporine—systemic lupus erythematosus	7.82e-05	0.000633	CcSEcCtD
Pioglitazone—Anaemia—Methotrexate—systemic lupus erythematosus	7.81e-05	0.000633	CcSEcCtD
Pioglitazone—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	7.81e-05	0.000633	CcSEcCtD
Pioglitazone—Feeling abnormal—Betamethasone—systemic lupus erythematosus	7.81e-05	0.000633	CcSEcCtD
Pioglitazone—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	7.69e-05	0.000623	CcSEcCtD
Pioglitazone—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	7.68e-05	0.000622	CcSEcCtD
Pioglitazone—Headache—Mycophenolate mofetil—systemic lupus erythematosus	7.63e-05	0.000618	CcSEcCtD
Pioglitazone—Malaise—Methotrexate—systemic lupus erythematosus	7.62e-05	0.000617	CcSEcCtD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—systemic lupus erythematosus	7.61e-05	0.00609	CbGpPWpGaD
Pioglitazone—Vertigo—Methotrexate—systemic lupus erythematosus	7.59e-05	0.000615	CcSEcCtD
Pioglitazone—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	7.59e-05	0.000615	CcSEcCtD
Pioglitazone—Urticaria—Dexamethasone—systemic lupus erythematosus	7.53e-05	0.00061	CcSEcCtD
Pioglitazone—Urticaria—Betamethasone—systemic lupus erythematosus	7.53e-05	0.00061	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	7.52e-05	0.000609	CcSEcCtD
Pioglitazone—Dizziness—Prednisolone—systemic lupus erythematosus	7.51e-05	0.000608	CcSEcCtD
Pioglitazone—Asthenia—Triamcinolone—systemic lupus erythematosus	7.49e-05	0.000607	CcSEcCtD
Pioglitazone—Asthenia—Methylprednisolone—systemic lupus erythematosus	7.48e-05	0.000606	CcSEcCtD
Pioglitazone—Insomnia—Prednisone—systemic lupus erythematosus	7.46e-05	0.000605	CcSEcCtD
Pioglitazone—Dizziness—Hydrocortisone—systemic lupus erythematosus	7.33e-05	0.000594	CcSEcCtD
Pioglitazone—SLCO1B1—Bile acid and bile salt metabolism—ALB—systemic lupus erythematosus	7.3e-05	0.00584	CbGpPWpGaD
Pioglitazone—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	7.25e-05	0.0058	CbGpPWpGaD
Pioglitazone—Arthralgia—Methotrexate—systemic lupus erythematosus	7.19e-05	0.000583	CcSEcCtD
Pioglitazone—Chest pain—Methotrexate—systemic lupus erythematosus	7.19e-05	0.000583	CcSEcCtD
Pioglitazone—Myalgia—Methotrexate—systemic lupus erythematosus	7.19e-05	0.000583	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	7.15e-05	0.000579	CcSEcCtD
Pioglitazone—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	7.13e-05	0.000578	CcSEcCtD
Pioglitazone—Fatigue—Prednisone—systemic lupus erythematosus	7.12e-05	0.000576	CcSEcCtD
Pioglitazone—Headache—Prednisolone—systemic lupus erythematosus	7.11e-05	0.000576	CcSEcCtD
Pioglitazone—Discomfort—Methotrexate—systemic lupus erythematosus	7.11e-05	0.000576	CcSEcCtD
Pioglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—systemic lupus erythematosus	7.1e-05	0.00568	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—GADD45A—systemic lupus erythematosus	7.07e-05	0.00566	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	6.99e-05	0.00559	CbGpPWpGaD
Pioglitazone—Headache—Hydrocortisone—systemic lupus erythematosus	6.95e-05	0.000563	CcSEcCtD
Pioglitazone—Dizziness—Triamcinolone—systemic lupus erythematosus	6.91e-05	0.000559	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	6.9e-05	0.000559	CcSEcCtD
Pioglitazone—Dizziness—Methylprednisolone—systemic lupus erythematosus	6.89e-05	0.000558	CcSEcCtD
Pioglitazone—Infection—Methotrexate—systemic lupus erythematosus	6.85e-05	0.000555	CcSEcCtD
Pioglitazone—PPARG—Adipogenesis—ADIPOQ—systemic lupus erythematosus	6.82e-05	0.00546	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Prednisone—systemic lupus erythematosus	6.8e-05	0.000551	CcSEcCtD
Pioglitazone—Asthenia—Dexamethasone—systemic lupus erythematosus	6.8e-05	0.000551	CcSEcCtD
Pioglitazone—Asthenia—Betamethasone—systemic lupus erythematosus	6.8e-05	0.000551	CcSEcCtD
Pioglitazone—Nervous system disorder—Methotrexate—systemic lupus erythematosus	6.76e-05	0.000548	CcSEcCtD
Pioglitazone—Skin disorder—Methotrexate—systemic lupus erythematosus	6.7e-05	0.000543	CcSEcCtD
Pioglitazone—PPARG—PPARA activates gene expression—RXRA—systemic lupus erythematosus	6.68e-05	0.00535	CbGpPWpGaD
Pioglitazone—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	6.67e-05	0.00054	CcSEcCtD
Pioglitazone—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	6.61e-05	0.00529	CbGpPWpGaD
Pioglitazone—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	6.61e-05	0.00529	CbGpPWpGaD
Pioglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	6.57e-05	0.00526	CbGpPWpGaD
Pioglitazone—Urticaria—Prednisone—systemic lupus erythematosus	6.56e-05	0.000531	CcSEcCtD
Pioglitazone—PPARG—Transcription factor regulation in adipogenesis—IL6—systemic lupus erythematosus	6.55e-05	0.00524	CbGpPWpGaD
Pioglitazone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	6.55e-05	0.00524	CbGpPWpGaD
Pioglitazone—Headache—Triamcinolone—systemic lupus erythematosus	6.54e-05	0.00053	CcSEcCtD
Pioglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	6.54e-05	0.00523	CbGpPWpGaD
Pioglitazone—Headache—Methylprednisolone—systemic lupus erythematosus	6.53e-05	0.000529	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—systemic lupus erythematosus	6.5e-05	0.00521	CbGpPWpGaD
Pioglitazone—Diarrhoea—Betamethasone—systemic lupus erythematosus	6.48e-05	0.000525	CcSEcCtD
Pioglitazone—Diarrhoea—Dexamethasone—systemic lupus erythematosus	6.48e-05	0.000525	CcSEcCtD
Pioglitazone—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	6.39e-05	0.00512	CbGpPWpGaD
Pioglitazone—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	6.28e-05	0.000509	CcSEcCtD
Pioglitazone—Dizziness—Dexamethasone—systemic lupus erythematosus	6.27e-05	0.000508	CcSEcCtD
Pioglitazone—Dizziness—Betamethasone—systemic lupus erythematosus	6.27e-05	0.000508	CcSEcCtD
Pioglitazone—Insomnia—Methotrexate—systemic lupus erythematosus	6.24e-05	0.000505	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—systemic lupus erythematosus	6.23e-05	0.00499	CbGpPWpGaD
Pioglitazone—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.16e-05	0.00493	CbGpPWpGaD
Pioglitazone—Dyspnoea—Methotrexate—systemic lupus erythematosus	6.15e-05	0.000498	CcSEcCtD
Pioglitazone—Hypersensitivity—Prednisone—systemic lupus erythematosus	6.08e-05	0.000493	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	5.95e-05	0.000482	CcSEcCtD
Pioglitazone—Fatigue—Methotrexate—systemic lupus erythematosus	5.95e-05	0.000482	CcSEcCtD
Pioglitazone—Headache—Betamethasone—systemic lupus erythematosus	5.94e-05	0.000481	CcSEcCtD
Pioglitazone—Headache—Dexamethasone—systemic lupus erythematosus	5.94e-05	0.000481	CcSEcCtD
Pioglitazone—Asthenia—Prednisone—systemic lupus erythematosus	5.92e-05	0.00048	CcSEcCtD
Pioglitazone—PPARG—Adipogenesis—RXRA—systemic lupus erythematosus	5.84e-05	0.00468	CbGpPWpGaD
Pioglitazone—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	5.84e-05	0.00467	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—systemic lupus erythematosus	5.78e-05	0.00463	CbGpPWpGaD
Pioglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	5.7e-05	0.00456	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Methotrexate—systemic lupus erythematosus	5.68e-05	0.00046	CcSEcCtD
Pioglitazone—Diarrhoea—Prednisone—systemic lupus erythematosus	5.65e-05	0.000457	CcSEcCtD
Pioglitazone—Urticaria—Methotrexate—systemic lupus erythematosus	5.48e-05	0.000444	CcSEcCtD
Pioglitazone—Dizziness—Prednisone—systemic lupus erythematosus	5.46e-05	0.000442	CcSEcCtD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	5.28e-05	0.00422	CbGpPWpGaD
Pioglitazone—Headache—Prednisone—systemic lupus erythematosus	5.17e-05	0.000419	CcSEcCtD
Pioglitazone—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	5.16e-05	0.00413	CbGpPWpGaD
Pioglitazone—Hypersensitivity—Methotrexate—systemic lupus erythematosus	5.08e-05	0.000412	CcSEcCtD
Pioglitazone—Asthenia—Methotrexate—systemic lupus erythematosus	4.95e-05	0.000401	CcSEcCtD
Pioglitazone—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	4.91e-05	0.00393	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—ADIPOQ—systemic lupus erythematosus	4.81e-05	0.00385	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—NR3C1—systemic lupus erythematosus	4.76e-05	0.00381	CbGpPWpGaD
Pioglitazone—PPARG—Regulation of retinoblastoma protein—CDKN1B—systemic lupus erythematosus	4.73e-05	0.00379	CbGpPWpGaD
Pioglitazone—Diarrhoea—Methotrexate—systemic lupus erythematosus	4.72e-05	0.000382	CcSEcCtD
Pioglitazone—PPARG—Adipogenesis—FAS—systemic lupus erythematosus	4.62e-05	0.00369	CbGpPWpGaD
Pioglitazone—Dizziness—Methotrexate—systemic lupus erythematosus	4.56e-05	0.000369	CcSEcCtD
Pioglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	4.51e-05	0.00361	CbGpPWpGaD
Pioglitazone—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	4.38e-05	0.00351	CbGpPWpGaD
Pioglitazone—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	4.37e-05	0.0035	CbGpPWpGaD
Pioglitazone—PPARG—Regulation of retinoblastoma protein—CDKN1A—systemic lupus erythematosus	4.36e-05	0.00349	CbGpPWpGaD
Pioglitazone—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	4.36e-05	0.00349	CbGpPWpGaD
Pioglitazone—Headache—Methotrexate—systemic lupus erythematosus	4.32e-05	0.00035	CcSEcCtD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—systemic lupus erythematosus	4.21e-05	0.00337	CbGpPWpGaD
Pioglitazone—PPARG—Regulation of retinoblastoma protein—EP300—systemic lupus erythematosus	4.15e-05	0.00332	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	4.14e-05	0.00332	CbGpPWpGaD
Pioglitazone—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	4.03e-05	0.00323	CbGpPWpGaD
Pioglitazone—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	4e-05	0.0032	CbGpPWpGaD
Pioglitazone—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.98e-05	0.00319	CbGpPWpGaD
Pioglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	3.97e-05	0.00318	CbGpPWpGaD
Pioglitazone—PPARG—Signaling events mediated by HDAC Class I—EP300—systemic lupus erythematosus	3.96e-05	0.00317	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	3.82e-05	0.00306	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	3.77e-05	0.00302	CbGpPWpGaD
Pioglitazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	3.76e-05	0.00301	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.72e-05	0.00298	CbGpPWpGaD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—systemic lupus erythematosus	3.67e-05	0.00294	CbGpPWpGaD
Pioglitazone—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.55e-05	0.00284	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—SNRPD1—systemic lupus erythematosus	3.53e-05	0.00282	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	3.41e-05	0.00273	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—NAT2—systemic lupus erythematosus	3.37e-05	0.00269	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.32e-05	0.00266	CbGpPWpGaD
Pioglitazone—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	3.27e-05	0.00262	CbGpPWpGaD
Pioglitazone—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.27e-05	0.00262	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—FAS—systemic lupus erythematosus	3.26e-05	0.00261	CbGpPWpGaD
Pioglitazone—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	3.24e-05	0.00259	CbGpPWpGaD
Pioglitazone—PPARG—Signaling events mediated by HDAC Class I—TNF—systemic lupus erythematosus	3.22e-05	0.00257	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MTA2—systemic lupus erythematosus	3.19e-05	0.00255	CbGpPWpGaD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—systemic lupus erythematosus	3.19e-05	0.00255	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	3.18e-05	0.00254	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—NAT2—systemic lupus erythematosus	3.1e-05	0.00248	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	3.07e-05	0.00246	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.05e-05	0.00244	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	3.03e-05	0.00242	CbGpPWpGaD
Pioglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—systemic lupus erythematosus	2.98e-05	0.00239	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—LYN—systemic lupus erythematosus	2.9e-05	0.00232	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	2.9e-05	0.00232	CbGpPWpGaD
Pioglitazone—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.82e-05	0.00226	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	2.78e-05	0.00222	CbGpPWpGaD
Pioglitazone—PPARG—PPARA activates gene expression—EP300—systemic lupus erythematosus	2.76e-05	0.00221	CbGpPWpGaD
Pioglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	2.7e-05	0.00216	CbGpPWpGaD
Pioglitazone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	2.63e-05	0.00211	CbGpPWpGaD
Pioglitazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	2.62e-05	0.0021	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—CDKN1A—systemic lupus erythematosus	2.54e-05	0.00203	CbGpPWpGaD
Pioglitazone—CYP2C19—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.52e-05	0.00202	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—PTPRC—systemic lupus erythematosus	2.48e-05	0.00199	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.44e-05	0.00195	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—ADIPOQ—systemic lupus erythematosus	2.34e-05	0.00188	CbGpPWpGaD
Pioglitazone—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	2.3e-05	0.00184	CbGpPWpGaD
Pioglitazone—SLCO1B3—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	2.23e-05	0.00179	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—TNFSF13—systemic lupus erythematosus	2.16e-05	0.00173	CbGpPWpGaD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	2.14e-05	0.00171	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	2.13e-05	0.00171	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	2.11e-05	0.00169	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.1e-05	0.00168	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—TGFB1—systemic lupus erythematosus	2.1e-05	0.00168	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—SNRPB—systemic lupus erythematosus	2.09e-05	0.00167	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	2.02e-05	0.00162	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—RXRA—systemic lupus erythematosus	2.01e-05	0.00161	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2e-05	0.0016	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	2e-05	0.0016	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—TNF—systemic lupus erythematosus	1.96e-05	0.00157	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—VDR—systemic lupus erythematosus	1.93e-05	0.00155	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	1.89e-05	0.00151	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.88e-05	0.0015	CbGpPWpGaD
Pioglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	1.86e-05	0.00149	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.79e-05	0.00144	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	1.74e-05	0.00139	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	1.74e-05	0.00139	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	1.72e-05	0.00138	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—EP300—systemic lupus erythematosus	1.7e-05	0.00136	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—JAK1—systemic lupus erythematosus	1.69e-05	0.00135	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.68e-05	0.00134	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—NAT2—systemic lupus erythematosus	1.67e-05	0.00134	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—IL6—systemic lupus erythematosus	1.58e-05	0.00127	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.51e-05	0.00121	CbGpPWpGaD
Pioglitazone—SLCO1B1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	1.5e-05	0.0012	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—NAT2—systemic lupus erythematosus	1.43e-05	0.00114	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.41e-05	0.00113	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.34e-05	0.00108	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.33e-05	0.00106	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.26e-05	0.00101	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.19e-05	0.000955	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—JUNB—systemic lupus erythematosus	1.17e-05	0.000938	CbGpPWpGaD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.14e-05	0.000909	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	1.13e-05	0.000908	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NAT2—systemic lupus erythematosus	1.12e-05	0.000898	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—IL6—systemic lupus erythematosus	1.12e-05	0.000893	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TYK2—systemic lupus erythematosus	1.11e-05	0.00089	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.04e-05	0.000836	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—RXRA—systemic lupus erythematosus	1.03e-05	0.000822	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.02e-05	0.000815	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	9.98e-06	0.000799	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—RXRA—systemic lupus erythematosus	9.36e-06	0.00075	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—VDR—systemic lupus erythematosus	9.31e-06	0.000745	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	8.92e-06	0.000714	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.91e-06	0.000713	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MMP9—systemic lupus erythematosus	8.75e-06	0.000701	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.69e-06	0.000695	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—NR3C1—systemic lupus erythematosus	8.38e-06	0.00067	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—EP300—systemic lupus erythematosus	8.3e-06	0.000664	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.12e-06	0.00065	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	8.02e-06	0.000642	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—RXRA—systemic lupus erythematosus	7.99e-06	0.00064	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.93e-06	0.000635	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—VEGFA—systemic lupus erythematosus	7.86e-06	0.000629	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.63e-06	0.00061	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.41e-06	0.000593	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.25e-06	0.00058	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TGFB1—systemic lupus erythematosus	7.21e-06	0.000577	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	7.13e-06	0.000571	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.02e-06	0.000562	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—TNF—systemic lupus erythematosus	6.74e-06	0.000539	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.61e-06	0.000529	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	6.45e-06	0.000516	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—RXRA—systemic lupus erythematosus	6.29e-06	0.000504	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.24e-06	0.0005	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PPARG—systemic lupus erythematosus	5.91e-06	0.000473	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.84e-06	0.000467	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	5.76e-06	0.000461	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	5.6e-06	0.000448	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—IL6—systemic lupus erythematosus	5.44e-06	0.000435	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ALB—systemic lupus erythematosus	5.32e-06	0.000426	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	5.29e-06	0.000424	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	5.25e-06	0.00042	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.19e-06	0.000416	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.13e-06	0.00041	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—NOS3—systemic lupus erythematosus	5.09e-06	0.000407	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTGS2—systemic lupus erythematosus	4.65e-06	0.000372	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.61e-06	0.000369	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.57e-06	0.000366	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ALB—systemic lupus erythematosus	4.54e-06	0.000363	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—NOS3—systemic lupus erythematosus	4.34e-06	0.000347	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.17e-06	0.000334	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.11e-06	0.000329	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.03e-06	0.000323	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPARG—systemic lupus erythematosus	3.97e-06	0.000318	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—systemic lupus erythematosus	3.97e-06	0.000318	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—EP300—systemic lupus erythematosus	3.87e-06	0.00031	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.75e-06	0.0003	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	3.62e-06	0.000289	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.6e-06	0.000288	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—systemic lupus erythematosus	3.57e-06	0.000286	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	3.53e-06	0.000283	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.46e-06	0.000277	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NOS3—systemic lupus erythematosus	3.42e-06	0.000273	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.35e-06	0.000268	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—EP300—systemic lupus erythematosus	3.3e-06	0.000264	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.28e-06	0.000263	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	3.23e-06	0.000258	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—systemic lupus erythematosus	3.18e-06	0.000254	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—systemic lupus erythematosus	3.12e-06	0.00025	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	3.04e-06	0.000243	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.99e-06	0.00024	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	2.97e-06	0.000238	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	2.94e-06	0.000236	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	2.78e-06	0.000223	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.73e-06	0.000218	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—EP300—systemic lupus erythematosus	2.6e-06	0.000208	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—EP300—systemic lupus erythematosus	2.31e-06	0.000185	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	2.28e-06	0.000183	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	2.05e-06	0.000164	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	2.04e-06	0.000163	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	1.96e-06	0.000157	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.94e-06	0.000155	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.87e-06	0.00015	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	1.86e-06	0.000149	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	1.83e-06	0.000147	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	1.8e-06	0.000144	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	1.75e-06	0.00014	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	1.69e-06	0.000135	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.67e-06	0.000134	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	1.61e-06	0.000129	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	1.6e-06	0.000128	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.6e-06	0.000128	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	1.49e-06	0.00012	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	1.47e-06	0.000118	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	1.46e-06	0.000117	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	1.33e-06	0.000107	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	1.23e-06	9.81e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.23e-06	9.81e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	1.22e-06	9.73e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.1e-06	8.82e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.05e-06	8.43e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	9.64e-07	7.71e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	8.02e-07	6.42e-05	CbGpPWpGaD
